Cargando…

Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217079/
https://www.ncbi.nlm.nih.gov/pubmed/25333676
http://dx.doi.org/10.1038/mtna.2014.55
_version_ 1782342348085133312
collection PubMed
description
format Online
Article
Text
id pubmed-4217079
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42170792014-11-07 Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies Mol Ther Nucleic Acids Corrigendum Nature Publishing Group 2014-10 2014-10-21 /pmc/articles/PMC4217079/ /pubmed/25333676 http://dx.doi.org/10.1038/mtna.2014.55 Text en Copyright © 2014 American Society of Gene & Cell Therapy
spellingShingle Corrigendum
Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title_full Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title_fullStr Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title_full_unstemmed Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title_short Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy for Tauopathies
title_sort antisense-mediated exon skipping decreases tau protein expression: a potential therapy for tauopathies
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217079/
https://www.ncbi.nlm.nih.gov/pubmed/25333676
http://dx.doi.org/10.1038/mtna.2014.55